Our center is based at King’s College Hospital in London. The clinic receives referrals from all over the world, and acts as a tertiary referral centre for patients from the South East. In a typical year we will see about 200 new patients and fill 400 follow-up slots making this one of the busiest MND clinics in the world.
MAGNET is an innovative clinical platform trial in which multiple treatments for ALS are investigated simultaneously.
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.